Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) is a growing public health concern with few effective treatment options. We use human genetics to identify genes associated with MASLD and investigate their roles in metabolism using in vitro cell systems and genetically modified mouse models.